Skip to main content

New Products: Roche

Premium

Roche this week launched its Complete His-Tag purification column for purifying histidine-tagged proteins from cell lysates.

The column uses Roche's nickel-chelate chemistry and is compatible with commonly used reducing agents, metalloproteinase inhibiting reagents, and different buffer and salt environments allowing researchers to choose optimal conditions, the company said. Additionally, the columns require no buffer exchange or resin recharging following purification.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.